Interpace Diagnostics
Christopher McCarthy is a seasoned CPA with a strong background in finance and operations. With experience in various financial roles at Simon and Schuster before joining Interpace Biosciences, Christopher now holds the positions of Chief Financial Officer, Vice President of Finance and Enterprise Systems, and Senior Director of Operations Finance. Their educational background includes a Master of Business Administration (MBA) in Accounting and a Bachelor of Science (BS) in Accounting from William Paterson University of New Jersey.
Interpace Diagnostics
Interpace Biosciences (OTCQX: IDXG) is a leader in enabling personalized medicine, offering specialized services along the therapeutic value chain from early diagnosis and prognostic planning to targeted therapeutic applications.